Dan T. Vogl, MD, MSCE is Associate Professor of Medicine in the Division of Hematology and Oncology at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. Dr. Vogl sees patients with multiple myeloma, amyloidosis, and other plasma cell cancers. His clinical and translational research focuses on early phase clinical trials of novel therapies for relapsed and refractory multiple myeloma. Dr. Vogl also serves as Medical Director of the Abramson Cancer Center’s Clinical Research Unit, overseeing the work of over 140 research nurses, research coordinators, regulatory coordinators, and biospecimen coordinators, who together manage over 300 active cancer clinical trials. He is a member of Penn’s Myeloma Program, Amyloidosis Program, and Cellular Therapy and Transplant Program.